Order Article Reprints

Bertapelle C, Carillo MR, Cacciola NA, Shidlovskii YV, Peluso G, Digilio FA. The Reversible Carnitine Palmitoyltransferase 1 Inhibitor (Teglicar) Ameliorates the Neurodegenerative Phenotype in a Drosophila Huntington’s Disease Model by Acting on the Expression of Carnitine-Related Genes. Molecules. 2022; 27(10):3125. https://doi.org/10.3390/molecules27103125

Bertapelle, Carla, Maria Rosaria Carillo, Nunzio Antonio Cacciola, Yulii V. Shidlovskii, Gianfranco Peluso, and Filomena Anna Digilio. 2022. "The Reversible Carnitine Palmitoyltransferase 1 Inhibitor (Teglicar) Ameliorates the Neurodegenerative Phenotype in a Drosophila Huntington’s Disease Model by Acting on the Expression of Carnitine-Related Genes" Molecules 27, no. 10: 3125. https://doi.org/10.3390/molecules27103125

Bertapelle, C., Carillo, M. R., Cacciola, N. A., Shidlovskii, Y. V., Peluso, G., & Digilio, F. A. (2022). The Reversible Carnitine Palmitoyltransferase 1 Inhibitor (Teglicar) Ameliorates the Neurodegenerative Phenotype in a Drosophila Huntington’s Disease Model by Acting on the Expression of Carnitine-Related Genes. Molecules, 27(10), 3125. https://doi.org/10.3390/molecules27103125